Adult T-Cell Leukemia (ATL)
3 clinical trials · Condition
◉ Watch Adult T-Cell Leukemia (ATL)
| Record | Firm | Date |
|---|---|---|
| Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) (NCT02689453) | National Cancer Institute (NCI) | 2017-01-19 |
| Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia (NCT00924170) | National Cancer Institute (NCI) | 2008-10-31 |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia (NCT00664677) | Erimos Pharmaceuticals | 2007-08-01 |
Track Adult T-Cell Leukemia (ATL) automatically
Every clearance here is in the API, with alerts when new ones post.